CNC vs TBPH · P/E 8.4, rev $103.52B vs P/E 7.5, rev $38.4M
Centene Corp (CNC) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported CNC revenue for 2026-06-30 was $103.52B. Net income was $2.63B. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the CNC and TBPH stock pages for the full models.
Not investment advice.